The deal size was increased to $350M from $250M and priced below last closing price of $21.31. Jefferies, Leerink and BofA are acting as joint book running managers for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
- Why is Biotech Stock iBio Up over 50%?
- Wave Life Sciences price target raised to $34 from $12 at Cantor Fitzgerald
- Wave Life Sciences price target raised to $40 from $19 at Canaccord
- Wave Life Sciences price target raised to $29 from $16 at Wells Fargo